Cargando…

P53 germline mutations in childhood cancers and cancer risk for carrier individuals

The family history of cancer in children treated for a solid malignant tumour in the Paediatric Oncology Department at Institute Gustave-Roussy, has been investigated. In order to determine the role of germline p53 mutations in genetic predisposition to childhood cancer, germline p53 mutations were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chompret, A, Brugières, L, Ronsin, M, Gardes, M, Dessarps-Freichey, F, Abel, A, Hua, D, Ligot, L, Dondon, M-G, Paillerets, B Bressac-de, Frébourg, T, Lemerle, J, Bonaïti-Pellié, C, Feunteun, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363254/ https://www.ncbi.nlm.nih.gov/pubmed/10864200 http://dx.doi.org/10.1054/bjoc.2000.1167

Ejemplares similares

Sex differences in cancer risk among germline p53 mutation carriers
por: Chompret, A, et al.
Publicado: (2004)

Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program
por: Helbling-Leclerc, Anne, et al.
Publicado: (2019)

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
por: Lesueur, F, et al.
Publicado: (2008)

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

Germline Mutations of Inhibins in Early-Onset Ovarian Epithelial Tumors
por: Tournier, Isabelle, et al.
Publicado: (2014)

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours
por: Marian, C, et al.
Publicado: (2005)

Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16(INK4A), P14(ARF) or cdk4 genes
por: Soufir, N, et al.
Publicado: (2000)

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2
por: Rapley, E A, et al.
Publicado: (2000)

Power comparison of different methods to detect genetic effects and gene-environment interactions
por: Kazma, Rémi, et al.
Publicado: (2007)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

Risk of colorectal cancer for carriers of a germline mutation in POLE or POLD1
por: Buchanan, Daniel D., et al.
Publicado: (2017)

The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma
por: Hubert, Jean-Noël, et al.
Publicado: (2021)

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes
por: Win, A K, et al.
Publicado: (2011)

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage
por: Zerdoumi, Yasmine, et al.
Publicado: (2017)

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage
por: Zerdoumi, Yasmine, et al.
Publicado: (2017)

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
por: Janin, N, et al.
Publicado: (1999)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers.
por: Jaïs, P., et al.
Publicado: (1998)

RARE-21. CANCER SPECTRUM IN GERMLINE SUFU MUTATION CARRIERS: A COLLABORATIVE PROJECT OF THE SIOPE HOST GENOME WORKING GROUP
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Melanoma Risk and Melanocyte Biology
por: BERTRAND, Juliette U., et al.
Publicado: (2020)

Extensive molecular screening for hereditary non-polyposis colorectal cancer
por: Dieumegard, B, et al.
Publicado: (2000)

PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010)

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies
por: Morganti, Stefania, et al.
Publicado: (2023)

Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
por: Packwood, Kate, et al.
Publicado: (2019)

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

A genetic and linguistic analysis of the admixture histories of the islands of Cabo Verde
por: Laurent, Romain, et al.
Publicado: (2023)

Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023)

Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
por: Metzger-Filho, Otto, et al.
Publicado: (2021)

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers
por: van der Post, Rachel S, et al.
Publicado: (2015)

The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations
por: Adamson, Aaron W., et al.
Publicado: (2020)

EPID-04. PREDCAP, the French registry of predisposition to pediatric cancers
por: Guerrini-Rousseau, Lea, et al.
Publicado: (2022)

Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation
por: Macedo, Gabriel S., et al.
Publicado: (2012)

Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark
por: Stoltze, Ulrik, et al.
Publicado: (2018)

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
por: Wang-Gohrke, S, et al.
Publicado: (1999)

Blood functional assay for rapid clinical interpretation of germline TP53 variants
por: Raad, Sabine, et al.
Publicado: (2021)

Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000)

Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer
por: Jin, Hei-Ying, et al.
Publicado: (2008)

The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
por: Mandelker, Diana, et al.
Publicado: (2019)

Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
por: Mizukami, Keijiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rthtj9pm2sca1pq52tf3ovtdmr